Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $394.1500 (0.61%) ($386.4300 - $396.2300) on Mon. Oct. 8, 2018. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.64% (three month average) | | RSI | 56 | | Latest Price | $394.1500(0.61%) | | Stocks Behave Similarly | Similar Stock List | | Weekly Trend | REGN advances 1% a week on average for past two weeks. | | Market Behavior | Rotation from growth to value for large cap. Rotation from growth to value for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | | Factors Impacting REGN price | REGN will decline at least -0.82% in a week (0% probabilities).
VXX(-12%) UUP(-11%) TLT(-7%) VIXM(-4%) IFRA(-3%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.82% (StdDev 1.64%) | | Hourly BBV | 0 () | | Intraday Trend | 0.7% | | | | | |
|
| 5 Day Moving Average | $396.32(-0.55%) | | 10 Day Moving Average | $396.71(-0.65%) | | 20 Day Moving Average | $393.46(0.18%) | | To recent high | -3.5% | | To recent low | 8.9% | | Market Cap | $41.791b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |